| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Tumor Markers, Biological | 16 | 2004 | 112 |
Why?
|
RNA-Binding Proteins | 12 | 2007 | 55 |
Why?
|
Neoplasm Proteins | 10 | 2007 | 110 |
Why?
|
Lung Neoplasms | 10 | 2004 | 159 |
Why?
|
Mesothelioma | 5 | 2008 | 22 |
Why?
|
Carcinoma, Neuroendocrine | 6 | 2007 | 9 |
Why?
|
Pleural Neoplasms | 4 | 2008 | 18 |
Why?
|
Carcinoid Tumor | 4 | 2007 | 20 |
Why?
|
Immunohistochemistry | 21 | 2007 | 355 |
Why?
|
Melanoma | 4 | 2008 | 87 |
Why?
|
Skin Neoplasms | 4 | 2008 | 97 |
Why?
|
Potassium Channels, Voltage-Gated | 7 | 1998 | 17 |
Why?
|
Adenocarcinoma | 6 | 2008 | 167 |
Why?
|
Potassium Channels | 7 | 1996 | 33 |
Why?
|
Carcinoma, Small Cell | 3 | 2007 | 20 |
Why?
|
Lymph Nodes | 3 | 2008 | 106 |
Why?
|
Mediastinal Neoplasms | 2 | 2008 | 21 |
Why?
|
Transcription Factors | 2 | 2011 | 201 |
Why?
|
Pleural Effusion, Malignant | 3 | 2008 | 10 |
Why?
|
Diagnosis, Differential | 9 | 2007 | 402 |
Why?
|
Nevus | 3 | 2008 | 11 |
Why?
|
Heart | 2 | 1999 | 88 |
Why?
|
Myocardium | 7 | 1996 | 119 |
Why?
|
Humans | 41 | 1999 | 1856 |
Why?
|
Mediastinum | 2 | 2008 | 18 |
Why?
|
Lymphatic Metastasis | 3 | 2008 | 77 |
Why?
|
Myocytes, Cardiac | 6 | 2004 | 40 |
Why?
|
Neoplasm Invasiveness | 2 | 2009 | 105 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2011 | 16 |
Why?
|
Sarcoma, Synovial | 1 | 2010 | 3 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 5 |
Why?
|
Solitary Fibrous Tumors | 1 | 2010 | 4 |
Why?
|
Aged | 15 | 2003 | 988 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2010 | 7 |
Why?
|
Nuclear Proteins | 2 | 2010 | 139 |
Why?
|
Male | 26 | 1992 | 1553 |
Why?
|
Fibroma | 1 | 2009 | 19 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2009 | 14 |
Why?
|
Carcinoma, Endometrioid | 1 | 2009 | 7 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2009 | 7 |
Why?
|
Adult | 17 | 2001 | 1317 |
Why?
|
Parathyroid Neoplasms | 1 | 2009 | 9 |
Why?
|
Femoral Neck Fractures | 1 | 2008 | 9 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2008 | 7 |
Why?
|
Fractures, Spontaneous | 1 | 2008 | 12 |
Why?
|
Heart Ventricles | 9 | 1996 | 86 |
Why?
|
Action Potentials | 7 | 1994 | 77 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 6 |
Why?
|
Female | 23 | 1992 | 1643 |
Why?
|
Pleural Effusion | 1 | 2008 | 24 |
Why?
|
Carcinoma, Large Cell | 1 | 2007 | 4 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2007 | 15 |
Why?
|
Leiomyoma | 1 | 2009 | 34 |
Why?
|
Uterine Neoplasms | 1 | 2009 | 52 |
Why?
|
Malacoplakia | 1 | 2007 | 7 |
Why?
|
Inclusion Bodies | 1 | 2007 | 20 |
Why?
|
Bone Neoplasms | 1 | 2008 | 83 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 71 |
Why?
|
Middle Aged | 13 | 2003 | 1161 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 241 |
Why?
|
Reactive Oxygen Species | 1 | 2008 | 112 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 204 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2004 | 3 |
Why?
|
Papilloma | 1 | 2004 | 7 |
Why?
|
RNA, Messenger | 3 | 1996 | 394 |
Why?
|
Prostate | 1 | 2007 | 55 |
Why?
|
Aged, 80 and over | 7 | 2007 | 599 |
Why?
|
Papillomaviridae | 1 | 2004 | 37 |
Why?
|
Neoplasms | 1 | 2010 | 239 |
Why?
|
Neoplasms, Second Primary | 1 | 2004 | 31 |
Why?
|
Genes, Dominant | 2 | 1998 | 68 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2004 | 111 |
Why?
|
Pulmonary Valve | 1 | 2001 | 11 |
Why?
|
Lung | 5 | 2004 | 232 |
Why?
|
Precancerous Conditions | 3 | 2008 | 29 |
Why?
|
Mice, Transgenic | 7 | 1998 | 209 |
Why?
|
Hyperplasia | 2 | 2009 | 55 |
Why?
|
Mice | 15 | 1998 | 623 |
Why?
|
Pleura | 2 | 2008 | 18 |
Why?
|
Airway Obstruction | 2 | 2006 | 29 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2007 | 53 |
Why?
|
Calcium-Binding Protein, Vitamin D-Dependent | 2 | 2008 | 14 |
Why?
|
Predictive Value of Tests | 2 | 2009 | 321 |
Why?
|
Electrophysiology | 5 | 1994 | 101 |
Why?
|
Animals | 20 | 1992 | 1031 |
Why?
|
Biopsy, Fine-Needle | 2 | 2007 | 17 |
Why?
|
Prognosis | 3 | 2008 | 388 |
Why?
|
Cardiomegaly | 2 | 2005 | 36 |
Why?
|
Cysteine Endopeptidases | 2 | 2007 | 41 |
Why?
|
Haemophilus Infections | 2 | 2007 | 30 |
Why?
|
Adolescent | 6 | 2003 | 891 |
Why?
|
Haemophilus influenzae | 2 | 2007 | 39 |
Why?
|
Cyclic AMP Response Element Modulator | 2 | 2005 | 7 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 2 | 2005 | 8 |
Why?
|
Shal Potassium Channels | 4 | 1998 | 1 |
Why?
|
Tomography, X-Ray Computed | 3 | 2007 | 321 |
Why?
|
Carotid Sinus | 2 | 1992 | 7 |
Why?
|
Patch-Clamp Techniques | 6 | 1998 | 47 |
Why?
|
Immunoenzyme Techniques | 2 | 2004 | 125 |
Why?
|
Ion Channel Gating | 1 | 1996 | 42 |
Why?
|
Lysophosphatidylcholines | 1 | 1994 | 25 |
Why?
|
Membrane Potentials | 3 | 1999 | 99 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2010 | 5 |
Why?
|
Ion Channels | 1 | 1994 | 61 |
Why?
|
Myocardial Ischemia | 1 | 1994 | 62 |
Why?
|
Locus Coeruleus | 1 | 1992 | 13 |
Why?
|
Adrenergic Fibers | 1 | 1992 | 13 |
Why?
|
Oxidopamine | 1 | 1992 | 21 |
Why?
|
Neoplasm Staging | 2 | 2009 | 125 |
Why?
|
Prostatic Neoplasms | 2 | 2007 | 120 |
Why?
|
Adenoma, Liver Cell | 1 | 2010 | 2 |
Why?
|
YY1 Transcription Factor | 1 | 2010 | 4 |
Why?
|
Neuroendocrine Cells | 1 | 2010 | 5 |
Why?
|
Cholangiocarcinoma | 1 | 2010 | 7 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 16 |
Why?
|
CA-125 Antigen | 1 | 2010 | 2 |
Why?
|
Carcinoma, Papillary | 1 | 2010 | 16 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2010 | 8 |
Why?
|
Bile Duct Neoplasms | 1 | 2010 | 8 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 10 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 277 |
Why?
|
Peritoneal Neoplasms | 1 | 2010 | 24 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2009 | 9 |
Why?
|
Cell Proliferation | 2 | 2010 | 227 |
Why?
|
Feedback, Physiological | 2 | 2005 | 26 |
Why?
|
Pulmonary Fibrosis | 1 | 2010 | 48 |
Why?
|
Pancreatic Neoplasms | 2 | 2007 | 46 |
Why?
|
Long QT Syndrome | 2 | 1998 | 35 |
Why?
|
Thyroid Neoplasms | 1 | 2010 | 43 |
Why?
|
Apoptosis | 2 | 2005 | 265 |
Why?
|
Second Messenger Systems | 1 | 2009 | 19 |
Why?
|
Meningeal Neoplasms | 1 | 2010 | 30 |
Why?
|
Mice, Inbred C57BL | 5 | 1999 | 318 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2009 | 9 |
Why?
|
Liver Neoplasms | 1 | 2010 | 97 |
Why?
|
Calmodulin | 1 | 2009 | 34 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2009 | 8 |
Why?
|
Enzyme Activation | 2 | 2007 | 177 |
Why?
|
Muscle Fibers, Skeletal | 2 | 1996 | 21 |
Why?
|
Lymphoma | 1 | 2010 | 96 |
Why?
|
Pneumonia, Lipid | 1 | 2008 | 3 |
Why?
|
Hyperparathyroidism | 1 | 2009 | 16 |
Why?
|
Petrolatum | 1 | 2008 | 5 |
Why?
|
Antigens, CD44 | 1 | 2008 | 18 |
Why?
|
Crack Cocaine | 1 | 2008 | 7 |
Why?
|
Urologic Neoplasms | 1 | 2008 | 8 |
Why?
|
Cocaine-Related Disorders | 1 | 2008 | 22 |
Why?
|
Urothelium | 1 | 2008 | 15 |
Why?
|
Pericardial Effusion | 1 | 2008 | 18 |
Why?
|
Ascitic Fluid | 1 | 2008 | 20 |
Why?
|
Electric Conductivity | 2 | 1996 | 42 |
Why?
|
Ear, Middle | 1 | 2007 | 11 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 427 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2007 | 11 |
Why?
|
Transforming Growth Factor beta | 2 | 2007 | 99 |
Why?
|
Ovarian Neoplasms | 1 | 2009 | 64 |
Why?
|
Calcium | 2 | 1996 | 208 |
Why?
|
Ventricular Function | 2 | 1996 | 23 |
Why?
|
Lymphocytes | 1 | 2009 | 142 |
Why?
|
Hydrogen Peroxide | 1 | 2008 | 75 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2007 | 8 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2004 | 82 |
Why?
|
Carcinoma, Islet Cell | 1 | 2007 | 1 |
Why?
|
Gastritis | 1 | 2007 | 8 |
Why?
|
Pyelonephritis | 1 | 2007 | 15 |
Why?
|
Calcium Signaling | 1 | 2009 | 52 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2006 | 4 |
Why?
|
Reproducibility of Results | 1 | 2010 | 391 |
Why?
|
Potassium | 2 | 1996 | 98 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 112 |
Why?
|
Pulmonary Eosinophilia | 1 | 2006 | 8 |
Why?
|
Membrane Glycoproteins | 1 | 2010 | 154 |
Why?
|
Brain Neoplasms | 1 | 2010 | 116 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2007 | 10 |
Why?
|
Tumor Suppressor Proteins | 1 | 2007 | 51 |
Why?
|
Transcription Factor RelA | 1 | 2007 | 36 |
Why?
|
Pneumocystis Infections | 1 | 2006 | 12 |
Why?
|
Rats | 6 | 1992 | 530 |
Why?
|
Inflammation | 2 | 2007 | 208 |
Why?
|
Hypercholesterolemia | 1 | 2007 | 33 |
Why?
|
Carrier Proteins | 1 | 2010 | 177 |
Why?
|
Dilatation, Pathologic | 2 | 2001 | 15 |
Why?
|
Disease Progression | 1 | 2008 | 244 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 279 |
Why?
|
Ventricular Remodeling | 1 | 2005 | 21 |
Why?
|
T-Lymphocyte Subsets | 1 | 2006 | 70 |
Why?
|
Membrane Proteins | 1 | 2010 | 233 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2004 | 23 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 15 |
Why?
|
Cells, Cultured | 4 | 1999 | 447 |
Why?
|
Retinoblastoma Protein | 1 | 2004 | 26 |
Why?
|
Cardiomyopathies | 1 | 2004 | 43 |
Why?
|
DNA, Neoplasm | 1 | 2004 | 75 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 126 |
Why?
|
Membrane Transport Proteins | 1 | 2004 | 43 |
Why?
|
Electrocardiography | 4 | 1998 | 132 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 78 |
Why?
|
Papillomavirus Infections | 1 | 2004 | 39 |
Why?
|
Aortic Diseases | 1 | 2003 | 15 |
Why?
|
Rats, Inbred Strains | 2 | 1992 | 170 |
Why?
|
Hypertension | 1 | 2007 | 161 |
Why?
|
DNA, Viral | 1 | 2004 | 98 |
Why?
|
Blotting, Western | 3 | 1996 | 275 |
Why?
|
Aorta | 1 | 2003 | 69 |
Why?
|
Reflex | 2 | 1992 | 33 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2002 | 16 |
Why?
|
Endocarditis | 1 | 2002 | 12 |
Why?
|
Cell Line | 3 | 1998 | 375 |
Why?
|
Aortic Valve Insufficiency | 1 | 2001 | 15 |
Why?
|
Aortic Valve | 1 | 2001 | 19 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 1999 | 243 |
Why?
|
Transplantation, Autologous | 1 | 2001 | 78 |
Why?
|
Reoperation | 1 | 2001 | 106 |
Why?
|
Promoter Regions, Genetic | 2 | 1999 | 188 |
Why?
|
Signal Transduction | 2 | 2005 | 313 |
Why?
|
Postoperative Complications | 2 | 2001 | 305 |
Why?
|
Shab Potassium Channels | 1 | 1999 | 3 |
Why?
|
Delayed Rectifier Potassium Channels | 1 | 1999 | 8 |
Why?
|
Myosin Heavy Chains | 1 | 1999 | 14 |
Why?
|
Human Growth Hormone | 1 | 1999 | 21 |
Why?
|
Heart Atria | 1 | 1999 | 37 |
Why?
|
Protein Isoforms | 1 | 1999 | 86 |
Why?
|
Macromolecular Substances | 1 | 1999 | 92 |
Why?
|
Kinetics | 2 | 1999 | 349 |
Why?
|
Tissue Array Analysis | 2 | 2008 | 27 |
Why?
|
Up-Regulation | 3 | 1998 | 183 |
Why?
|
Gene Expression | 3 | 2001 | 291 |
Why?
|
Elapid Venoms | 1 | 1996 | 3 |
Why?
|
Tetraethylammonium Compounds | 1 | 1996 | 5 |
Why?
|
Tetraethylammonium | 1 | 1996 | 9 |
Why?
|
Neurotoxins | 1 | 1996 | 33 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 2 | 2005 | 6 |
Why?
|
Peptide Fragments | 1 | 1998 | 144 |
Why?
|
Blood Pressure | 3 | 1992 | 205 |
Why?
|
Treatment Outcome | 1 | 2004 | 661 |
Why?
|
Luciferases | 2 | 2005 | 70 |
Why?
|
Injections, Intraventricular | 2 | 1992 | 21 |
Why?
|
Time Factors | 2 | 1998 | 896 |
Why?
|
NF-kappa B | 2 | 2007 | 114 |
Why?
|
Papillary Muscles | 1 | 1994 | 14 |
Why?
|
Guinea Pigs | 1 | 1994 | 76 |
Why?
|
Rats, Sprague-Dawley | 2 | 2005 | 257 |
Why?
|
Mice, Knockout | 3 | 1998 | 265 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1996 | 119 |
Why?
|
Age Factors | 1 | 1996 | 480 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 1992 | 15 |
Why?
|
Arrhythmias, Cardiac | 1 | 1994 | 65 |
Why?
|
Microinjections | 1 | 1992 | 30 |
Why?
|
Norepinephrine | 1 | 1992 | 68 |
Why?
|
Thoracic Cavity | 1 | 2010 | 3 |
Why?
|
Mediastinoscopy | 1 | 2010 | 4 |
Why?
|
Thoracotomy | 1 | 2010 | 14 |
Why?
|
GPI-Linked Proteins | 1 | 2010 | 11 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2010 | 13 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 164 |
Why?
|
Organ Specificity | 1 | 2010 | 104 |
Why?
|
Isoproterenol | 1 | 2009 | 47 |
Why?
|
Cyclic GMP | 1 | 2009 | 30 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 21 |
Why?
|
Actins | 1 | 2010 | 112 |
Why?
|
Biopsy | 1 | 2010 | 207 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 89 |
Why?
|
Angiotensin II | 1 | 2009 | 31 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2007 | 5 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2007 | 4 |
Why?
|
Serpin E2 | 1 | 2007 | 3 |
Why?
|
MAP Kinase Kinase 3 | 1 | 2007 | 3 |
Why?
|
Biological Markers | 1 | 2010 | 262 |
Why?
|
Streptolysins | 1 | 2007 | 10 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 104 |
Why?
|
Serpins | 1 | 2007 | 14 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2007 | 51 |
Why?
|
Mice, Mutant Strains | 1 | 2007 | 77 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2007 | 18 |
Why?
|
Fibroblasts | 1 | 2010 | 179 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 45 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 216 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2007 | 39 |
Why?
|
Immunoprecipitation | 1 | 2007 | 57 |
Why?
|
alpha-Fetoproteins | 1 | 2007 | 12 |
Why?
|
Pneumococcal Infections | 1 | 2007 | 31 |
Why?
|
Acetylation | 1 | 2007 | 46 |
Why?
|
Respiratory Function Tests | 1 | 2006 | 72 |
Why?
|
Fatal Outcome | 1 | 2007 | 86 |
Why?
|
Smad3 Protein | 1 | 2007 | 26 |
Why?
|
Streptococcus pneumoniae | 1 | 2007 | 38 |
Why?
|
Serine Endopeptidases | 1 | 2006 | 28 |
Why?
|
RNA Interference | 1 | 2007 | 75 |
Why?
|
Doxorubicin | 1 | 2007 | 60 |
Why?
|
Kv Channel-Interacting Proteins | 1 | 2005 | 1 |
Why?
|
CD4 Lymphocyte Count | 1 | 2006 | 50 |
Why?
|
Pneumocystis carinii | 1 | 2006 | 18 |
Why?
|
HeLa Cells | 1 | 2007 | 107 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 210 |
Why?
|
Mice, SCID | 1 | 2006 | 61 |
Why?
|
Fatty Acid Transport Proteins | 1 | 2004 | 2 |
Why?
|
Genomics | 1 | 2005 | 36 |
Why?
|
Conserved Sequence | 1 | 2005 | 73 |
Why?
|
Diastole | 1 | 2004 | 21 |
Why?
|
Hypertrophy | 1 | 2004 | 46 |
Why?
|
Positron-Emission Tomography | 1 | 2004 | 32 |
Why?
|
Cell Size | 1 | 2004 | 68 |
Why?
|
Cell Differentiation | 1 | 2010 | 262 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2006 | 91 |
Why?
|
Bacterial Proteins | 1 | 2007 | 99 |
Why?
|
Biological Transport | 1 | 2004 | 129 |
Why?
|
Elasticity | 1 | 2003 | 30 |
Why?
|
Heart Rate | 1 | 2005 | 138 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 189 |
Why?
|
Heart Failure | 1 | 2007 | 106 |
Why?
|
Risk Factors | 1 | 2010 | 555 |
Why?
|
Child, Preschool | 1 | 2009 | 554 |
Why?
|
Glucose | 1 | 2004 | 120 |
Why?
|
Stress, Mechanical | 1 | 2003 | 93 |
Why?
|
Kv1.5 Potassium Channel | 1 | 2001 | 1 |
Why?
|
Equipment Failure | 1 | 2002 | 44 |
Why?
|
Indicators and Reagents | 1 | 2001 | 79 |
Why?
|
Cardiac Surgical Procedures | 1 | 2002 | 35 |
Why?
|
Luminescent Proteins | 1 | 2001 | 67 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 105 |
Why?
|
Protein Processing, Post-Translational | 1 | 2001 | 78 |
Why?
|
Kv1.4 Potassium Channel | 1 | 1999 | 1 |
Why?
|
Child | 1 | 2009 | 749 |
Why?
|
Transfection | 1 | 2001 | 237 |
Why?
|
Kidney | 1 | 2001 | 223 |
Why?
|
Point Mutation | 1 | 1998 | 122 |
Why?
|
Algorithms | 1 | 1999 | 226 |
Why?
|
Yohimbine | 1 | 1992 | 10 |
Why?
|
Phenoxybenzamine | 1 | 1992 | 12 |
Why?
|
Rats, Wistar | 1 | 1992 | 75 |
Why?
|
Logistic Models | 1 | 1992 | 251 |
Why?
|
